Variant report
Variant | nsv1009296 |
---|---|
Chromosome Location | chr1:215498152-215520123 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:215500545..215503507-chr1:215504494..215507015,2 | K562 | blood: | |
2 | chr1:215507541..215509380-chr1:215510952..215512628,2 | K562 | blood: | |
3 | chr1:215507541..215509380-chr1:215510952..215512628,2 | K562 | blood: | |
4 | chr1:215485891..215487601-chr1:215497785..215499384,2 | MCF-7 | breast: | |
5 | chr1:215500545..215503507-chr1:215504494..215507015,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554038168 | chr1:215498164-215498165 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538545913 | chr1:215498171-215498172 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
3 | rs367736323 | chr1:215498188-215498189 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547560079 | chr1:215498621-215498622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs12076291 | chr1:215498630-215498631 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs532071422 | chr1:215498635-215498636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548529373 | chr1:215498668-215498669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541469689 | chr1:215498679-215498680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11120553 | chr1:215498798-215498799 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs375872754 | chr1:215498813-215498814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548241801 | chr1:215498819-215498820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs568339909 | chr1:215498830-215498831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534102135 | chr1:215498834-215498835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs370088720 | chr1:215498854-215498855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553650642 | chr1:215498929-215498930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs138479498 | chr1:215498933-215498934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534239040 | chr1:215498996-215498997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11120554 | chr1:215499002-215499003 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs149625546 | chr1:215499084-215499085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552308146 | chr1:215499091-215499092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541803903 | chr1:215499125-215499126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561771937 | chr1:215499135-215499136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572371818 | chr1:215499180-215499181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs77847586 | chr1:215499182-215499183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190175268 | chr1:215499199-215499200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144330418 | chr1:215499245-215499246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs562588576 | chr1:215499258-215499259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369309882 | chr1:215499275-215499276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs531462145 | chr1:215499298-215499299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182115282 | chr1:215499327-215499328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs568078471 | chr1:215499330-215499331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs148751377 | chr1:215499381-215499382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs142316528 | chr1:215499387-215499388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs185012377 | chr1:215499444-215499445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34582533 | chr1:215499496-215499497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs35418621 | chr1:215499499-215499500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570702419 | chr1:215499548-215499549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115420800 | chr1:215499585-215499586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190934431 | chr1:215499586-215499587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs114451012 | chr1:215499619-215499620 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556917692 | chr1:215499636-215499637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs372897688 | chr1:215499736-215499737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535571600 | chr1:215499766-215499767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533254106 | chr1:215499777-215499778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375865717 | chr1:215499818-215499819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555303360 | chr1:215499821-215499822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs12035620 | chr1:215499834-215499835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572113815 | chr1:215499835-215499836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs377540765 | chr1:215499848-215499849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs2202679 | chr1:215499850-215499851 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Holoprosencephaly | 19184110 | CNVD |
Breast cancer | 21069454 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Developmental delay | 21147756 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:215497000-215498200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:215498600-215499400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr1:215499400-215504000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr1:215504000-215504400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr1:215504400-215506200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr1:215506200-215507800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr1:215517200-215519200 | Enhancers | Adipose Nuclei | Adipose |
8 | chr1:215517200-215519400 | Enhancers | Fetal Lung | lung |
9 | chr1:215517400-215519600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr1:215518000-215518200 | Enhancers | Right Atrium | heart |
11 | chr1:215518000-215518400 | Enhancers | Fetal Stomach | stomach |
12 | chr1:215518400-215520200 | Weak transcription | Right Atrium | heart |
13 | chr1:215519000-215519400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr1:215519400-215530600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |